11/21
11:56 am
docs
Rating for DOCS
Low
Report
Rating for DOCS
11/21
11:56 am
docs
Rating for DOCS
Low
Report
Rating for DOCS
11/21
07:10 am
docs
Doximity (NASDAQ:DOCS) was upgraded by analysts at Raymond James Financial, Inc. from an "outperform" rating to a "strong-buy" rating.
Medium
Report
Doximity (NASDAQ:DOCS) was upgraded by analysts at Raymond James Financial, Inc. from an "outperform" rating to a "strong-buy" rating.
11/21
05:00 am
docs
Doximity upgraded to Strong Buy from Outperform at Raymond James
Medium
Report
Doximity upgraded to Strong Buy from Outperform at Raymond James
11/21
05:00 am
docs
Doximity upgraded to Strong Buy from Outperform at Raymond James
Medium
Report
Doximity upgraded to Strong Buy from Outperform at Raymond James
11/13
08:11 am
docs
Doximity (NASDAQ:DOCS) is now covered by analysts at BMO Capital Markets. They set a "market perform" rating and a $55.00 price target on the stock.
Medium
Report
Doximity (NASDAQ:DOCS) is now covered by analysts at BMO Capital Markets. They set a "market perform" rating and a $55.00 price target on the stock.
11/13
04:36 am
docs
Rating for DOCS
Low
Report
Rating for DOCS
11/13
04:36 am
docs
Rating for DOCS
Low
Report
Rating for DOCS
11/12
04:14 pm
docs
Doximity initiated with a Market Perform at BMO Capital
Low
Report
Doximity initiated with a Market Perform at BMO Capital
11/12
04:14 pm
docs
Doximity initiated with a Market Perform at BMO Capital
Low
Report
Doximity initiated with a Market Perform at BMO Capital
11/10
03:27 pm
docs
Rating for DOCS
Low
Report
Rating for DOCS
11/7
09:17 am
docs
Rating for DOCS
Medium
Report
Rating for DOCS
10/27
08:06 am
docs
Doximity (NASDAQ:DOCS) was upgraded by analysts at Bank of America Corporation from a "neutral" rating to a "buy" rating. They now have a $62.00 price target on the stock.
Low
Report
Doximity (NASDAQ:DOCS) was upgraded by analysts at Bank of America Corporation from a "neutral" rating to a "buy" rating. They now have a $62.00 price target on the stock.
10/10
08:06 am
docs
Doximity (NASDAQ:DOCS) had its "underweight" rating reaffirmed by analysts at JPMorgan Chase & Co.. They now have a $62.00 price target on the stock.
Medium
Report
Doximity (NASDAQ:DOCS) had its "underweight" rating reaffirmed by analysts at JPMorgan Chase & Co.. They now have a $62.00 price target on the stock.
10/10
07:42 am
docs
Rating for DOCS
Medium
Report
Rating for DOCS
10/10
05:43 am
docs
Doximity downgraded to Underweight from Neutral at JPMorgan
Medium
Report
Doximity downgraded to Underweight from Neutral at JPMorgan
10/8
09:10 am
docs
Rating for DOCS
Medium
Report
Rating for DOCS
10/8
08:57 am
docs
Rating for DOCS
Medium
Report
Rating for DOCS
10/8
08:57 am
docs
Rating for DOCS
Medium
Report
Rating for DOCS
10/1
01:34 pm
docs
Rating for DOCS
Low
Report
Rating for DOCS
10/1
01:34 pm
docs
Rating for DOCS
Low
Report
Rating for DOCS
10/1
01:34 pm
docs
Rating for DOCS
Low
Report
Rating for DOCS
10/1
05:16 am
docs
Doximity downgraded to Sell from Neutral at Goldman Sachs
Low
Report
Doximity downgraded to Sell from Neutral at Goldman Sachs
10/1
05:16 am
docs
Doximity downgraded to Sell from Neutral at Goldman Sachs
Low
Report
Doximity downgraded to Sell from Neutral at Goldman Sachs
10/1
05:16 am
docs
Doximity downgraded to Sell from Neutral at Goldman Sachs
Low
Report
Doximity downgraded to Sell from Neutral at Goldman Sachs